Multimodal imaging and photothermal/chemodynamic therapy of cervical cancer using GSH-responsive MoS(2)@MnO(2) theranostic nanoparticles

The development of nanoparticles capable of inducing reactive oxygen species (ROS) formation has become an important strategy for cancer therapy. Simultaneously, the preparation of multifunctional nanoparticles that respond to the tumor microenvironment is crucial for the diagnosis and treatment of tumors. In this study, we designed a Molybdenum disulfide (MoS(2)) core coated with Manganese dioxide (MnO(2)), which possessed a good photothermal effect and could produce Fenton-like Mn(2+) in response to highly expressed glutathione (GSH) in the tumor microenvironment, thereby generating a chemodynamic therapy (CDT). The nanoparticles were further modified with Methoxypoly(Ethylene Glycol) 2000 (mPEG-NH(2)) to improve their biocompatibility, resulting in the formation of MoS(2)@MnO(2)-PEG. These nanoparticles were shown to possess significant Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) imaging capabilities, making them useful in tumor diagnosis. In vitro and in vivo experiments demonstrated the antitumor ability of MoS(2)@MnO(2)-PEG, with a significant killing effect on tumor cells under combined treatment. These nanoparticles hold great potential for CDT/photothermal therapy (PTT) combined antitumor therapy and could be further explored in biomedical research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s11671-023-03902-9.